Department of Internal Medicine, The University of Iowa, Iowa City, IA 52242, United States.
Vascul Pharmacol. 2011 Nov-Dec;55(5-6):143-8. doi: 10.1016/j.vph.2011.07.002. Epub 2011 Jul 12.
BACKGROUND/AIMS: Reduced activity of the antioxidant glutathione peroxidase-1 (GPx1) correlates with increased risk of cardiovascular events in patients with coronary artery disease. However, it remains unclear whether this imbalance in antioxidant capacity directly contributes to activation of vascular cells. In response to oxidative stress, smooth muscle cells (SMCs) secrete the pro-inflammatory immunomodulator cyclophilin A (CyPA). We hypothesized that reduction in vascular cell GPx1 activity causes secretion of CyPA and paracrine-mediated activation of NF-κB and proliferation of SMCs.
METHODS/RESULTS: Using a murine model of GPx1 deficiency (GPx1(+/-)), we found elevated levels of hydrogen peroxide levels and increased secretion of CyPA in both arterial segments and cultured SMCs as compared to wild type (WT). Conditioned media from GPx1(+/-) SMCs caused increased NF-κB activation of quiescent WT SMCs, and this was inhibited by the antioxidant N-acetyl-l-cysteine or by cyclosporine A (CsA). In co-culture experiments, SMCs derived from GPx1(+/-) aorta caused increased proliferation of WT SMCs, which was also inhibited by CsA.
Reduction in vascular cell GPx1 activity and the associated increase in oxidative stress cause CyPA-mediated paracrine activation of SMCs. These findings identify a novel mechanism by which an imbalance in antioxidant capacity may contribute to vascular disease.
背景/目的:抗氧化酶谷胱甘肽过氧化物酶-1(GPx1)活性降低与冠心病患者心血管事件风险增加相关。然而,这种抗氧化能力的失衡是否直接导致血管细胞的激活仍不清楚。在氧化应激的情况下,平滑肌细胞(SMC)会分泌促炎免疫调节剂亲环素 A(CyPA)。我们假设血管细胞 GPx1 活性的降低会导致 CyPA 的分泌,以及旁分泌介导的 NF-κB 激活和 SMC 的增殖。
方法/结果:使用 GPx1 缺陷(GPx1(+/-))的小鼠模型,我们发现与野生型(WT)相比,动脉段和培养的 SMC 中的过氧化氢水平升高,CyPA 分泌增加。来自 GPx1(+/-)SMC 的条件培养基引起静息 WT SMC 中 NF-κB 的激活增加,这可以被抗氧化剂 N-乙酰-l-半胱氨酸或环孢素 A(CsA)抑制。在共培养实验中,GPx1(+/-)主动脉衍生的 SMC 引起 WT SMC 的增殖增加,CsA 也可以抑制这种增殖。
血管细胞 GPx1 活性的降低和相关的氧化应激增加导致 CyPA 介导的 SMC 的旁分泌激活。这些发现确定了一种新的机制,即抗氧化能力的失衡可能导致血管疾病。